Took a position yesterday in this stock....The david Prentice issue is interestingLimited downside so more a gamble than calculated playCant perform any worse than some have lately....
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%